Evidence for
Alexander Vinokourov’s Stage 13 Blood-Doping Test and Astana’s Tour Withdrawal

Companion notes

Alexander Vinokourov’s positive blood-doping test and Astana’s Tour de France withdrawal

The contemporaneous record establishes that Alexander Vinokourov’s Stage 13 sample from the 2007 Tour de France was reported positive for blood doping, triggering immediate team discipline and Astana’s withdrawal from the race. Later reporting also documents his request for B-sample analysis, his denial of wrongdoing, and Reuters’ account that Astana ultimately dismissed him after the B sample was reported non-negative.

The Paper Trail & Official Records

The documentary trail is anchored in contemporaneous sports reporting and institutional news dispatches, not a criminal case file or court judgment. BBC Sport and the Los Angeles Times both reported that the Laboratoire National de Dépistage du Dopage found Vinokourov’s Stage 13 time-trial sample positive for blood doping, while Reuters later relayed Astana’s own explanation for his dismissal. These are reporting records of a laboratory result and team response, and they establish the sequence of public disclosure without substituting for an adjudicated legal finding. [S2], [S3], [S5]

The most specific technical explanation preserved in the contemporaneous coverage was that the sample contained two distinct types of red blood cells, the hallmark cited by the reporting as evidence of homologous blood doping. That description appears in the BBC and Sydney Morning Herald accounts as part of the anti-doping laboratory narrative, not as an independent medical review. Reuters’ later report also preserved the team’s statement that the B sample had been reported non-negative, showing how the file evolved through public statements rather than a published disciplinary opinion. [S3], [S4], [S5]

Forensic Chronology & Turning Points

The chronology is straightforward and tightly documented. On July 21, 2007, during the Albi Stage 13 time trial, Vinokourov’s sample was taken and later reported positive. Once the result became public, Astana moved quickly: by July 24, the team had withdrawn from the Tour de France and suspended Vinokourov with immediate effect. Contemporary accounts also record that he requested analysis of the B sample and denied doping, which marks the first procedural response to the adverse finding. [S2], [S3], [S4], [S5]

A second turning point came on July 30, when Reuters reported that Astana had sacked Vinokourov after receiving confirmation that the B sample was non-negative. That report is important because it distinguishes the team’s final employment decision from the earlier race withdrawal and provisional suspension. The timeline therefore shows a progression from laboratory flag, to public disclosure, to immediate team-wide withdrawal, and finally to formal dismissal. [S5], [S3]

Evidentiary Boundaries & Negative Findings

What the record does establish is limited but substantial: the positive sample, the team withdrawal, the immediate suspension, and the later Reuters account of a non-negative B sample and dismissal. What it does not establish is a judicial finding of guilt, nor does it supply a court ruling resolving the underlying anti-doping dispute. The sources describe contemporaneous test results and administrative consequences; they do not substitute for a final legal adjudication. [S2], [S3], [S5]

The reporting also preserves Vinokourov’s denial and his suggestion that the result may have been caused by blood pooling after a crash, but that explanation remains unproven in the cited record. Likewise, no source here demonstrates that the crash theory was accepted by the laboratory, the team, or a tribunal. The evidentiary boundary is therefore clear: the public record documents adverse test findings and team sanctions, while leaving any definitive exoneration or guilt determination unestablished. [S2], [S3], [S4], [S5]

Source key

The associated evidence packet contains visible source URLs, source roles and the complete claim ledger.